Pfm Health Sciences, LP Kura Oncology, Inc. Transaction History

Pfm Health Sciences, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$13.73 - $16.87 $15.7 Million - $19.3 Million	-1,143,917 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$10.6 - $17.49 $426,766 - $704,164	40,261 Added 3.65%	1,143,917 $16.1 Million
Q3 2018 Nov 13, 2018	BUY	$16.65 - $21.85 $275,274 - $361,246	16,533 Added 1.52%	1,103,656 $19.3 Million
Q2 2018 Aug 14, 2018	SELL	$14.8 - $18.8 $3.73 Million - $4.74 Million	-252,239 Reduced 18.83%	1,087,123 $19.8 Million
Q1 2018 May 15, 2018	SELL	$14.5 - $23.4 $5.99 Million - $9.66 Million	-412,762 Reduced 23.56%	1,339,362 $25.1 Million
Q4 2017 Feb 14, 2018	SELL	$13.5 - $16.65 $8.9 Million - $11 Million	-659,428 Reduced 27.34%	1,752,124 $26.8 Million
Q3 2017 Nov 14, 2017	BUY	$6.05 - $14.95 $14.6 Million - $36.1 Million	2,411,552	2,411,552 $36.1 Million

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $747M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.